139 related articles for article (PubMed ID: 25791968)
1. Primary prevention of congenital anomalies: recommendable, feasible and achievable.
Taruscio D; Mantovani A; Carbone P; Barisic I; Bianchi F; Garne E; Nelen V; Neville AJ; Wellesley D; Dolk H
Public Health Genomics; 2015; 18(3):184-91. PubMed ID: 25791968
[TBL] [Abstract][Full Text] [Related]
2. European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans.
Taruscio D; Arriola L; Baldi F; Barisic I; Bermejo-Sánchez E; Bianchi F; Calzolari E; Carbone P; Curran R; Garne E; Gatt M; Latos-Bieleńska A; Khoshnood B; Irgens L; Mantovani A; Martínez-Frías ML; Neville A; Rißmann A; Ruggeri S; Wellesley D; Dolk H
Public Health Genomics; 2014; 17(2):115-23. PubMed ID: 24714026
[TBL] [Abstract][Full Text] [Related]
3. Primary Prevention of Congenital Anomalies: Special Focus on Environmental Chemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases.
Taruscio D; Baldi F; Carbone P; Neville AJ; Rezza G; Rizzo C; Mantovani A
Adv Exp Med Biol; 2017; 1031():301-322. PubMed ID: 29214580
[TBL] [Abstract][Full Text] [Related]
4. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention as an essential factor ensuring sustainability of health systems: the example of congenital anomalies.
Taruscio D; Bermejo-Sánchez E; Salerno P; Mantovani A
Ann Ist Super Sanita; 2019; 55(3):258-264. PubMed ID: 31553320
[TBL] [Abstract][Full Text] [Related]
6. EUROCAT: 25 years of European surveillance of congenital anomalies.
Dolk H
Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F355-8. PubMed ID: 16113149
[TBL] [Abstract][Full Text] [Related]
7. [Primary prevention of congenital defects].
Nazer J
Rev Med Chil; 2004 Apr; 132(4):501-8. PubMed ID: 15382524
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of congenital anomalies in pregnancies with pregestational diabetes.
Garne E; Loane M; Dolk H; Barisic I; Addor MC; Arriola L; Bakker M; Calzolari E; Matias Dias C; Doray B; Gatt M; Melve KK; Nelen V; O'Mahony M; Pierini A; Randrianaivo-Ranjatoelina H; Rankin J; Rissmann A; Tucker D; Verellun-Dumoulin C; Wiesel A
Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):134-40. PubMed ID: 22371321
[TBL] [Abstract][Full Text] [Related]
9. Paper 1: The EUROCAT network--organization and processes.
Boyd PA; Haeusler M; Barisic I; Loane M; Garne E; Dolk H
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S2-15. PubMed ID: 21384531
[TBL] [Abstract][Full Text] [Related]
10. Pre-conception public health to address maternal obesity.
Mullins E; Murphy O; Davies SC
BJOG; 2016 Jan; 123(2):159-60. PubMed ID: 26841190
[No Abstract] [Full Text] [Related]
11. EUROPLAN: a project to support the development of national plans on rare diseases in Europe.
Taruscio D; Gentile AE; De Santis M; Ferrelli RM; Posada de la Paz M; Hens M; Huizer J; Fregonese L; Stefanov R; Bottarelli V; Weinman A; Le Cam Y; Gavhed D; Mincarone P; Bushby K; Frazzica RG; Donati C; Vittozzi L; Jessop E
Public Health Genomics; 2013; 16(6):278-87. PubMed ID: 24503588
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring of pregnancies exposed to drugs in France: the experience of the registries of congenital malformations].
Doray B
Therapie; 2014; 69(1):47-51. PubMed ID: 24698188
[TBL] [Abstract][Full Text] [Related]
13. Prevention, diagnosis and services.
Bermejo E; Martínez-Frías ML
Adv Exp Med Biol; 2010; 686():55-75. PubMed ID: 20824439
[TBL] [Abstract][Full Text] [Related]
14. Preconception care: caffeine, smoking, alcohol, drugs and other environmental chemical/radiation exposure.
Lassi ZS; Imam AM; Dean SV; Bhutta ZA
Reprod Health; 2014 Sep; 11 Suppl 3(Suppl 3):S6. PubMed ID: 25415846
[TBL] [Abstract][Full Text] [Related]
15. Congenital Anomalies: Cluster Detection and Investigation.
Bermejo-Sánchez E; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():535-557. PubMed ID: 29214591
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of congenital anomalies in Europe.
Dolk H; Loane M; Garne E
Adv Exp Med Biol; 2010; 686():349-64. PubMed ID: 20824455
[TBL] [Abstract][Full Text] [Related]
17. National plans and strategies on rare diseases in Europe.
Taruscio D; Vittozzi L; Stefanov R
Adv Exp Med Biol; 2010; 686():475-91. PubMed ID: 20824461
[TBL] [Abstract][Full Text] [Related]
18. Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? A population-based case-control study.
Bánhidy F; Dakhlaoui A; Puhó EH; Czeizel AA
Congenit Anom (Kyoto); 2011 Jun; 51(2):80-6. PubMed ID: 21039913
[TBL] [Abstract][Full Text] [Related]
19. Preconception Care of the Obese Woman.
Delcore L; Lacoursiere DY
Clin Obstet Gynecol; 2016 Mar; 59(1):129-39. PubMed ID: 26710304
[TBL] [Abstract][Full Text] [Related]
20. Folic acid and primary prevention of birth defects.
Taruscio D; Carbone P; Granata O; Baldi F; Mantovani A
Biofactors; 2011; 37(4):280-4. PubMed ID: 21915935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
